Prospective and prognostic factors for hepatic metastasis of gastric carcinoma: A retrospective analysis
Conclusions: The therapy design for patients with GCLM should consider the general conditions and personal clinicopathological characters of patients. After balancing the benefit and risk factors, multidisciplinary treatment and individual treatment should be developed based on evidence-based medicine model for each patient.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Jin Cheng Song Xiao Lei Ding Yang Zhang Xian Zhang Xiu Hua Sun Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Gastrectomy | Gastric (Stomach) Cancer | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Urology & Nephrology